全文获取类型
收费全文 | 3279篇 |
免费 | 250篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 122篇 |
妇产科学 | 121篇 |
基础医学 | 472篇 |
口腔科学 | 58篇 |
临床医学 | 237篇 |
内科学 | 897篇 |
皮肤病学 | 37篇 |
神经病学 | 229篇 |
特种医学 | 89篇 |
外科学 | 425篇 |
综合类 | 53篇 |
预防医学 | 136篇 |
眼科学 | 99篇 |
药学 | 187篇 |
中国医学 | 20篇 |
肿瘤学 | 333篇 |
出版年
2024年 | 4篇 |
2023年 | 26篇 |
2022年 | 45篇 |
2021年 | 90篇 |
2020年 | 48篇 |
2019年 | 84篇 |
2018年 | 79篇 |
2017年 | 55篇 |
2016年 | 94篇 |
2015年 | 83篇 |
2014年 | 104篇 |
2013年 | 160篇 |
2012年 | 217篇 |
2011年 | 246篇 |
2010年 | 127篇 |
2009年 | 108篇 |
2008年 | 150篇 |
2007年 | 179篇 |
2006年 | 163篇 |
2005年 | 212篇 |
2004年 | 193篇 |
2003年 | 204篇 |
2002年 | 216篇 |
2001年 | 103篇 |
2000年 | 75篇 |
1999年 | 78篇 |
1998年 | 45篇 |
1997年 | 42篇 |
1996年 | 32篇 |
1995年 | 21篇 |
1994年 | 15篇 |
1993年 | 16篇 |
1992年 | 34篇 |
1991年 | 20篇 |
1990年 | 23篇 |
1989年 | 35篇 |
1988年 | 10篇 |
1987年 | 20篇 |
1986年 | 19篇 |
1985年 | 10篇 |
1984年 | 10篇 |
1983年 | 7篇 |
1982年 | 11篇 |
1981年 | 7篇 |
1979年 | 5篇 |
1978年 | 5篇 |
1977年 | 3篇 |
1976年 | 5篇 |
1974年 | 4篇 |
1973年 | 6篇 |
排序方式: 共有3560条查询结果,搜索用时 15 毫秒
51.
Yoshifumi Nishi Chika Ogami Yasuhiro Tsuji Hitoshi Kawasuji Harumi Yamada Shin Kawai Ippei Sakamaki Hideto To Yoshihiro Yamamoto 《Journal of infection and chemotherapy》2021,27(2):165-171
IntroductionAims of this study were (a) to assess the development ratio of hyponatremia during treatment with linezolid and (b) to evaluate the relationship between the risk of hyponatremia and linezolid exposure and patient background.MethodClinical data including linezolid serum concentrations and serum sodium values were collected at Toyama University Hospital and Kyorin University Hospital. Data from 89 patients were used for the analysis, and a nadir serum sodium level ≤130 mmol/L during the treatment with linezolid was defined as hyponatremia. Mann-Whitney's U test was used to evaluate the effects of the area under the time-concentration curve (AUC) of linezolid at the nadir sodium level, clinical characteristics (e.g. laboratory data), and baseline serum sodium levels on the development of hyponatremia.ResultsThe hyponatremia was occurred in 21 of 89 patients (23.6%). Data are compared for baseline and nadir serum sodium levels of patients with and without hyponatremia. In both groups, nadir serum sodium levels were significantly different from those of the baseline values (P < 0.05). The values of AUC0-12, accumulated AUC, baseline serum sodium levels and age were significantly different between patients with and without hyponatremia (P < 0.05).ConclusionsLinezolid exposure, age, and baseline sodium levels were detected as the risk factors for linezolid-related hyponatremia. Our findings suggest that regular monitoring of serum sodium levels is desirable during treatment with linezolid, especially for the elderly and patients with low serum sodium levels before the start of linezolid administration. 相似文献
52.
Tomohiro Oishi Aki Saito Yoko Fukuda Atsushi Kato Eisuke Kondo Hideto Teranishi Hiroto Akaike Ippei Miyata Naoki Ohno Kazunobu Ouchi 《Journal of infection and chemotherapy》2021,27(2):342-347
IntroductionThe features of pneumonia in children with neurologic impairment (NI) resemble those of healthcare-associated pneumonia is defined as pneumonia occurring in the community associated with healthcare risk factors. There are currently no guidelines for the treatment of pneumonia in children with NI. Here, we assessed whether the guidelines applicable for treating pneumonia in adults could be applied to children with NI.MethodsBetween 2008 and 2019, we enrolled children with NI who developed pneumonia and were treated in the pediatric ward of Kawasaki Medical School Hospital. We evaluated patient characteristics, the frequency of isolation of multidrug-resistant (MDR) pathogens, and clinical outcomes.ResultsMDR pathogens were more frequently isolated from patients receiving tube feeding (TF) and/or with tracheostomy than from patients without these risk factors. Other risk factors, including a history of antibiotic therapy and methicillin-resistant Staphylococcus aureus isolation, recent hospitalization, residence in a nursing home or extended care facility, and low-dose, long-term macrolide therapy, did not significantly affect the frequency of MDR pathogen isolation. In patients receiving TF and/or with tracheostomy, treatment success was achieved in all cases treated with broad-spectrum antibiotics and 72.2% of cases treated with non-broad-spectrum antibiotics (P = 0.007). Conversely, among patients without these risk factors, no such difference was observed.ConclusionsOur findings indicate that the guideline to select antibiotics for treating pneumonia in children with NI should be simpler and more useful than the current guidelines for adult pneumonia, based on risk factor assessment for MDR pathogens. 相似文献
53.
54.
55.
56.
Bitnun A Sochett E Dick PT To T Jefferies C Babyn P Forbes J Read S King SM 《The Journal of clinical endocrinology and metabolism》2005,90(1):168-174
Previous pediatric studies have failed to demonstrate a clear association between protease inhibitor (PI) therapy and abnormal glucose homeostasis in HIV-infected children. To define more precisely the impact of PI therapy on glucose homeostasis in this population, we performed the insulin-modified frequent-sampling iv glucose tolerance test on 33 PI-treated and 15 PI-naive HIV-infected children. Other investigations included fasting serum lipids; glucose, insulin, and C-peptide; single-slice abdominal computed tomography; and, in a subset of PI-treated children, an oral glucose tolerance test.There were no differences between the two groups with respect to fasting serum insulin or C-peptide, homeostatic model assessment insulin resistance, or quantitative insulin sensitivity check index. The mean insulin sensitivity index of PI-treated and PI-naive children was 6.93 +/- 6.37 and 10.58 +/- 12.93 x 10(-4)min(-1) [microU/ml](-1), respectively (P = 0.17). The mean disposition index for the two groups was 1840 +/- 1575 and 3708 +/- 3005 x 10(-4)min(-1) (P = 0.013), respectively. After adjusting for potential confounding variables using multiple regression analysis, the insulin sensitivity index and disposition index of PI-treated children were significantly lower than that of PI-naive children (P = 0.01 for both). In PI-treated but not PI-naive children, insulin sensitivity correlated inversely with visceral adipose tissue area (r = -0.43, P = 0.01) and visceral to sc adipose tissue ratio (r = -0.49, P = 0.004). Mildly impaired glucose tolerance was noted in four of 21 PI-treated subjects tested.Our results demonstrate not only that PI therapy reduces insulin sensitivity in HIV-infected children but also that it impairs the beta-cell response to this reduction in insulin sensitivity and, in a subset of children, leads to the development of impaired glucose tolerance. The presence of insulin resistance, dyslipidemia, and the significant correlation of reduced insulin sensitivity with increased visceral adipose tissue content suggest that PI-containing highly active antiretroviral therapy is associated with the emergence of early features of a metabolic syndrome-like phenotype. 相似文献
57.
Kwan‐Lung Ko Wai‐Pan To Lung‐Yi Mak Wai‐Kay Seto Qin Ning James Fung Ching‐Lung Lai Man‐Fung Yuen 《Journal of viral hepatitis》2020,27(4):397-406
Real‐world studies examining reduction in risk of hepatocellular carcinoma (HCC) in patients receiving antivirals are limited by the small size of the studies, or by data insufficiency and heterogeneity with short follow‐up duration. We aimed to examine the real‐world long‐term outcome of patients receiving entecavir treatment on HCC incidence and HBsAg seroclearance. The incidence of HCC in 1225 entecavir‐treated patients between 2002 and 2015 was compared with the HCC incidence estimated using the REACH‐B, GAG‐HCC and CU‐HCC scores. Standardized incidence ratios (SIR) were calculated. The impact of entecavir treatment on HBsAg seroclearance was also explored. The median follow‐up of the cohort was 6.6 years, with 66 cases of HCC development. Using the REACH‐B model, the reduction of HCC risk was significant from year 6 onwards with SIR of 0.68 (95% CI 0.535‐0.866) at year 10. In subgroup patients without cirrhosis, consistent risk reduction was observed from the fifth year and the SIR reached 0.51 (95% CI 0.271‐0.704) by year 10. Benefit in cirrhotic patients was demonstrated when using the GAG‐HCC and CU‐HCC score, with the SIR at year 10 being 0.38 (95% CI 0.259‐0.544) and 0.46 (95% CI 0.314‐0.659), respectively. The cumulative rate of HBsAg seroclearance was 5.2%. HBsAg level at third year of treatment and baseline‐to‐3‐year percentage reduction was predictive of subsequent HBsAg seroclearance. In conclusion, long‐term entecavir therapy was associated with significant reduction in the risk of HCC in the real world. However, HBsAg seroclearance rate remained low. Additional therapy may be considered in patients with adverse predictive factors for subsequent HBsAg seroclearance. 相似文献
58.
Go Kuwata Terumi Kamisawa Koichi Koizumi Taku Tabata Seiichi Hara Sawako Kuruma Takashi Fujiwara Kazuro Chiba Hideto Egashira Junko Fujiwara Takeo Arakawa Kumiko Momma Shinichiro Horiguchi 《Gut and liver》2014,8(1):29-34
Background/Aims
Ulcerative colitis (UC) is sometimes associated with autoimmune pancreatitis (AIP). Infiltration of immunoglobulin G4 (IgG4)-positive plasma cells is sometimes detected in the colonic mucosa of AIP or UC patients. This study aimed to clarify the relation between UC and IgG4.Methods
Associations with UC were reviewed in 85 AIP patients. IgG4 immunostaining was performed on biopsy specimens from the colonic mucosa of 14 AIP and 32 UC patients.Results
UC was confirmed in two cases (type 1 AIP, n=1; suspected type 2 AIP, n=1). Abundant infiltration of IgG4-positive plasma cells in the colonic mucosa was detected in the case of suspected type 2 AIP with UC and two cases of type 1 AIP without colitis. Abundant infiltration of IgG4-positive plasma cells was detected in 10 UC cases (IgG4-present, 31%). Although 72% of IgG4-absent UC patients showed mild disease activity, 70% of IgG4-present patients showed moderate to severe disease activity (p<0.05).Conclusions
UC is sometimes associated with AIP, but it seems that UC is not a manifestation of IgG4-related disease. Infiltration of IgG4-positive plasma cells is sometimes detectable in the colonic mucosa of UC patients and is associated with disease activity. 相似文献59.
60.
Borges KS Castro-Gamero AM Moreno DA da Silva Silveira V Brassesco MS de Paula Queiroz RG de Oliveira HF Carlotti CG Scrideli CA Tone LG 《Journal of cancer research and clinical oncology》2012,138(3):405-414